Special cells, special considerations: The challenges of bringing embryonic stem cells from the laboratory to the clinic

R. C. Addis, Jeff W Bulte, J. D. Gearhart

Research output: Contribution to journalArticle

Abstract

Human embryonic stem (ES) cells are an attractive tool for cell-based therapies because of their limitless capacity for proliferation and their ability to differentiate into all cell types of the body. However, these features introduce certain unique risks that must be considered in developing transplantation strategies for clinical use. We outline these risks and examine current approaches to address them, both before and after transplantation.

Original languageEnglish (US)
Pages (from-to)386-389
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume83
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Embryonic Stem Cells
Transplantation
Cell- and Tissue-Based Therapy
Human Embryonic Stem Cells
Cell Body

ASJC Scopus subject areas

  • Pharmacology

Cite this

Special cells, special considerations : The challenges of bringing embryonic stem cells from the laboratory to the clinic. / Addis, R. C.; Bulte, Jeff W; Gearhart, J. D.

In: Clinical Pharmacology and Therapeutics, Vol. 83, No. 3, 03.2008, p. 386-389.

Research output: Contribution to journalArticle

@article{5f4ed4a2be1745bc933cebf0dab07764,
title = "Special cells, special considerations: The challenges of bringing embryonic stem cells from the laboratory to the clinic",
abstract = "Human embryonic stem (ES) cells are an attractive tool for cell-based therapies because of their limitless capacity for proliferation and their ability to differentiate into all cell types of the body. However, these features introduce certain unique risks that must be considered in developing transplantation strategies for clinical use. We outline these risks and examine current approaches to address them, both before and after transplantation.",
author = "Addis, {R. C.} and Bulte, {Jeff W} and Gearhart, {J. D.}",
year = "2008",
month = "3",
doi = "10.1038/sj.clpt.6100384",
language = "English (US)",
volume = "83",
pages = "386--389",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Special cells, special considerations

T2 - The challenges of bringing embryonic stem cells from the laboratory to the clinic

AU - Addis, R. C.

AU - Bulte, Jeff W

AU - Gearhart, J. D.

PY - 2008/3

Y1 - 2008/3

N2 - Human embryonic stem (ES) cells are an attractive tool for cell-based therapies because of their limitless capacity for proliferation and their ability to differentiate into all cell types of the body. However, these features introduce certain unique risks that must be considered in developing transplantation strategies for clinical use. We outline these risks and examine current approaches to address them, both before and after transplantation.

AB - Human embryonic stem (ES) cells are an attractive tool for cell-based therapies because of their limitless capacity for proliferation and their ability to differentiate into all cell types of the body. However, these features introduce certain unique risks that must be considered in developing transplantation strategies for clinical use. We outline these risks and examine current approaches to address them, both before and after transplantation.

UR - http://www.scopus.com/inward/record.url?scp=39449134791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449134791&partnerID=8YFLogxK

U2 - 10.1038/sj.clpt.6100384

DO - 10.1038/sj.clpt.6100384

M3 - Article

C2 - 18285783

AN - SCOPUS:39449134791

VL - 83

SP - 386

EP - 389

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3

ER -